HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis.

Abstract
Older adults exhibit higher morbidity and mortality from infectious diseases compared with those of the general population. The introduction and rapid spread of West Nile virus (WNV) throughout the continental United States since 1999 has highlighted the challenge of protecting older adults against emerging pathogens: to this day there is no therapy or vaccine approved for human use against West Nile encephalitis. In this study, we describe the characterization of T and B cell responses in old mice after vaccination with RepliVAX WN, a novel West Nile encephalitis vaccine based on single-cycle flavivirus particles. In adult mice, RepliVAX WN induced robust and long-lasting CD4(+) and CD8(+) T cell and Ab (B cell) responses against natural WNV epitopes, similar to those elicited by primary WNV infection. Primary and memory T and B cell responses in old mice against RepliVAX WN vaccination were significantly lower than those seen in younger mice, similar to the response of old mice to infection with WNV. Surprisingly, both the quality and the quantity of the recall Ab and T cell responses in vaccinated old mice were improved to equal or exceed those in adult animals. Moreover, these responses together (but not individually) were sufficient to protect both old and adult mice from severe WNV disease upon challenge. Therefore, at least two cycles of in vivo restimulation are needed for selection and expansion of protective lymphocytes in older populations, and live, single-cycle virus vaccines that stimulate both cellular and humoral immunity can protect older individuals against severe viral disease.
AuthorsJennifer L Uhrlaub, James D Brien, Douglas G Widman, Peter W Mason, Janko Nikolich-Zugich
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 186 Issue 7 Pg. 3882-91 (Apr 01 2011) ISSN: 1550-6606 [Electronic] United States
PMID21339368 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Vaccines, Attenuated
  • West Nile Virus Vaccines
Topics
  • Adaptive Immunity
  • Animals
  • B-Lymphocyte Subsets (immunology, pathology, virology)
  • CD4-Positive T-Lymphocytes (immunology, pathology, virology)
  • CD8-Positive T-Lymphocytes (immunology, pathology, virology)
  • Cellular Senescence (immunology)
  • Immunization, Secondary (methods)
  • Immunologic Memory
  • Lymphocyte Activation (immunology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • T-Lymphocyte Subsets (immunology, pathology, virology)
  • Vaccines, Attenuated (administration & dosage, immunology)
  • West Nile Fever (mortality, pathology, prevention & control)
  • West Nile Virus Vaccines (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: